US2023256089A1PendingUtilityA1
Immunotherapy For The Treatment Of Allergic Disease
Est. expiryAug 30, 2037(~11.1 yrs left)· nominal 20-yr term from priority
Inventors:Roberto Garcia-Ibanez
A61K 39/35A61P 37/08A61K 2039/54A61K 2039/542A61K 2039/545
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions and methods for the treatment of allergic disease include treating a subject in need thereof with a dosage of an allergen, wherein the allergen is administered to the subject’s oral vestibular space. In a preferred embodiment, the allergen is administered at night, thereby exploiting circadian rhythms in the subject’s immune response and enhancing the effectiveness of the treatment.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 - 16 . (canceled)
17 . A method for treating allergic disease in a human subject, the method comprising:
administering, at night, an allergen directly to a sublingual space.
18 . The method of claim 17 , wherein the administering an allergen directly to a sublingual space comprises administering the allergen in multiple doses over a first period of time.
19 . The method of claim 18 , wherein a concentration of the allergen increases over the first period of time.
20 . The method of claim 17 , further comprising administering the allergen directly to an oral vestibular space.
21 . The method of claim 20 , wherein the administering the allergen directly to an oral vestibular space comprises administering the allergen in multiple doses over a second period of time.
22 . The method of claim 21 , wherein a concentration of the allergen remains constant over the second period of time.Join the waitlist — get patent alerts
Track US2023256089A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.